[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - May 2004

  ANDA Number Generic Drug Name Applicant Approval Date
1 76-513 OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%   NOVEX PHARMA 5/14/2004 
2 75-988 PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION 5 MG (BASE)/ 5 ML   PADDOCK LABORATORIES, INC. 5/25/2004 
3 65-178 CLARITHROMYCIN TABLETS, USP 250 MG AND 500 MG   ROXANE LABORATORIES, INC. 5/25/2004 
4 76-887 TERBUTALINE SULFATE INJECTION, USP 1 MG/ML, PACKAGED IN 1 ML SINGLE-DOSE VIALS.   AMERICAN PHARMACEUTICAL PARTNERS, INC. 5/26/2004 
5 75-914 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS 150 MG (RLD = ZYBAN/GSK)   IMPAX LABORATORIES, INC. 5/27/2004 
6 76-449 MIDODRINE HYDROCHLORIDE TABLETS 2.5 MG AND 5 MG   IMPAX LABORATORIES, INC. 5/27/2004 
7 76-408 METRONIDAZOLE TOPICAL CREAM 0.75%   ALTANA INC. 5/28/2004 
8 40-540 PROCHLORPERAZINE EDISYLATE INJECTION, USP 5 MG (BASE)/ML; PACKAGED IN 10 MG (BASE)/2 ML SINGLE-DOSE VIALS AND 50 MG (BASE)/10 ML MULTIPLE-DOSE VIALS   BEDFORD LABORATORIES 5/28/2004 
9 76-231 OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%   ALCON INC. 5/14/2004 
10 76-622 OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%   BAUSCH & LOMB, INC. 5/14/2004 
11 76-300 FLUTICASONE PROPIONATE OINTMENT 0.005%   ALTANA INC. 5/14/2004 
12 76-743 PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS, USP 100 MG/325 MG   VINTAGE PHARMACEUTICALS, INC. 5/7/2004 
13 76-633 FLUTICASONE PROPIONATE CREAM 0.05%   ATRIX LABORATORIES, INC, 5/14/2004 
14 76-668 FLUTICASONE PROPIONATE OINTMENT 0.005%   CLAY-PARK LABS, INC. 5/14/2004 
15 76-793 FLUTICASONE PROPIONATE CREAM 0.05%   CLAY-PARK LABS, INC. 5/14/2004 
16 76-451 FLUTICASONE PROPIONATE CREAM 0.05%   ALTANA INC. 5/14/2004 
17 76-615 OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%   HI-TECH PHARMACAL CO., INC. 5/14/2004 
18 76-458 FLUOXETINE ORAL SOLUTION, USP 20 MG (BASE)/5 ML   PAR PHARMACEUTICAL, INC. 5/14/2004 
19 76-521 CARBIDOPA-LEVODOPA EXTENDED-RELEASE TABLETS 25 MG/100 MG, AND 50 MG/200 MG   IMPAX LABORATORIES, INC. 5/14/2004 
20 76-733 MORPHINE SULFATE EXTENDED-RELEASE TABLETS 15 MG   KV PHARMACEUTICAL COMPANY 5/19/2004 
21 76-720 MORPHINE SULFATE EXTENDED-RELEASE TABLETS 60 MG   KV PHARMACEUTICAL COMPANY 5/19/2004 
22 76-151 DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP 120 MG, 180 MG, 240 MG, AND 300 MG (ONCE-A-DAY DOSAGE)   TORPHARM INC. 5/20/2004 
23 65-089 AMOXICILLIN & CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP 200 MG/28.5 MG (BASE)/5 ML AND 400 MG/57 MG (BASE)/5 ML   TEVA PHARMACEUTICALS USA 5/25/2004 
24 76-104 ITRACONAZOLE CAPSULES 100 MG   EON LABS, INC. 5/28/2004 
25 76-216 AMMONIUM LACTATE LOTION 12% (BASE)   TARO PHARMACEUTICALS USA, INC. 5/28/2004 

Back to Top      Back to Approvals

Date created: June 16, 2004

horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research